Status:
RECRUITING
Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia
Lead Sponsor:
Asociación Colombiana de Hepatología
Collaborating Sponsors:
Hospital Pablo Tobón Uribe
Conditions:
Hepatitis C Virus Infection
Eligibility:
All Genders
18-100 years
Brief Summary
Introduction: Hepatitis C virus infection is a major cause of chronic hepatitis, cirrhosis, and liver cancer. The risk of developing cirrhosis for people with chronic infection with the virus ranges f...
Detailed Description
Research question ¿What is the prevalence of HCV in the population with risk factors for hepatitis C virus infection captured by screening with rapid tests in health care institutions in Colombia? T...
Eligibility Criteria
Inclusion
- Have at least one of the following risk factors for hepatitis C.
- Over 50 years of age with no risk factors.
- Over 18 years old and less than 50 years old with risk factors for hepatitis C. Persons who have received medical or dental interventions in health care settings.
- Persons who have had tattoos, body piercings, or scarification procedures. Persons with HIV or hepatitis B infection. Persons who inject drugs. Persons who have used intranasal drugs. Persons deprived of liberty and previously incarcerated persons. Anyone with abnormal liver tests or liver disease. Students, health care workers, or members of public safety (e.g. correctional service officers or police) who have come into contact with blood at work through needlestick or sharps injuries. Anyone who has undergone hemodialysis. Persons who received transfusions in Colombia before 1996. Persons with comorbidities potentially associated with CH: diabetes, ischemic heart disease, cryoglobulinemia, chronic renal failure, Sjögren's syndrome, hypothyroidism, lichen planus, rheumatoid arthritis, HIV, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, waldenstrom's macroglobulinemia.
- Individuals previously treated for HCV with sustained viral response in whom reinfection is suspected (individuals who continue to engage in risk behaviors)
- Accept to participate in the study by signing the informed consent form.
Exclusion
- Have or have had hepatitis C with a proven cure by viral load at 12 weeks after the end of treatment without risk behaviors for reinfection.
- Be on antiviral treatment against chronic hepatitis C virus.
- That the patient voluntarily and consciously refuses to sign the informed consent form or is unable to give it due to any type of physical and/or mental disability.
Key Trial Info
Start Date :
December 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
25669 Patients enrolled
Trial Details
Trial ID
NCT06155006
Start Date
December 16 2023
End Date
December 31 2024
Last Update
June 10 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Pablo Tobón Uribe
Medellín, Antioquia, Colombia, 050001
2
Hospital Universitario Julio Méndez Barreneche E.S.E.
Santa Marta, Magdalena Department, Colombia, 470005